New York, NY -- (SBWIRE) -- 01/09/2017 -- Oxygen supplement is the vital requirement for people suffering with respiratory illness. There are no definite contraindications of medical gas. Although, inspired concentration of medical oxygen should be limited in case of emphysema and chronic bronchitis patients and premature infants. The use of higher levels of medical oxygen increases the risk of pulmonary toxicity in patients administrating antibiotics such as nitrofurantoin bleomycin and amiodarone. Sometimes, compressed medical oxygen toxicity may lead to convulsions, retrolenticular fibroplasia in premature infants and retrosternal soreness associated with coughing and breathing difficulties. There are specific standards for handling and usage of the medical gas as to avoid risks and hazards associated to medical gases.

A sample of this report is available upon request @ http://www.persistencemarketresearch.com/samples/3740

Medical gases are any gaseous substance that meets medical purity standards and has application in a medical environment. Some of the medical gases are oxygen, carbon dioxide, medical air and nitrous oxide. Medical oxygen is an essential element to support respiration. Medical oxygen is widely used in the management of various acute and chronic health conditions. Medical oxygen is used for aid resuscitation, aid cardiovascular stability and provides life support for artificial ventilated patient. In addition, medical oxygen provides basis for modern anesthetic techniques. Medical oxygen also helps to restore tissue oxygen tension in conditions such as cardiac and respiratory arrest, cyanosis, COPD, shock, carbon monoxide poisoning, major trauma and severe hemorrhage. Medical oxygen is used in a hospital setting or pre-hospital setting to manage emergency situations. It is also used in the home setting to manage long-term health conditions.

North America dominates the global market for medical oxygen systems due to large number of aging population and growing need for long-term healthcare services. Asia is expected to show high growth rates in the next five years in global medical oxygen systems market. China and India are expected to be the fastest growing medical oxygen systems markets in Asia-Pacific region. Some of the key driving forces for medical oxygen systems market in emerging countries are large pool of patients, increasing healthcare expenditure, improving healthcare infrastructure and rising government funding.

In recent times there is increased use of medical oxygen systems due to increasing incidence of respiratory diseases. Rising aging population, increasing affordability of healthcare services, increasing cases of emergency medical care and increased government funding are some of the key factors driving the growth for global medical oxygen systems market. In addition, increasing healthcare awareness is also fuelling the growth of global medical oxygen systems market. However, lack of reimbursements and rising instances of medical gas and cylinder theft are some of the major factors restraining the growth for the global medical oxygen systems market.

New innovations such as portable oxygen concentrators and rapid technological advancement would develop opportunities for the global medical oxygen systems market. However, strict regulatory requirement for production, standards, use and handling medical oxygen results in high costs; it could lead a challenge for the global medical oxygen systems market.

To view TOC of this report is available upon request @ http://www.persistencemarketresearch.com/toc/3740

Some of the major companies operating in the global medical oxygen systems market are Beijing Orient Medical Gas, Keen Compressed Gas, Atlas Copco, Cryofab, Inc., GF Health Products, Ohio Medical Corporation, Philips Respironics, Ingen Technologies and SMS Specialized Medical Services.